Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease
- PMID: 12426058
- DOI: 10.1016/s0006-8993(02)03514-x
Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease
Abstract
We have detected granular and filamentous inclusions that are alpha-synuclein- and ubiquitin-immunoreactive in the cytoplasm of dopaminergic and cortical neurons of C57/black mice treated chronically with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and probenecid. The immunoreactive aggregates only become evident several weeks after large-scale dopaminergic cell death and a downregulation of alpha-synuclein gene expression. Numerous lipofuscin granules accumulate alpha-synuclein in the nigral and limbic cortical neurons of treated mice. These data provide evidence that insoluble proteins, such as alpha-synuclein, build up as granular and filamentous inclusions in dopaminergic neurons that survive the initial toxic MPTP insult. They further suggest that defective protein degradation rather than altered gene expression underlies deposition of alpha-synuclein and that abundant lysosomal compartments are present to seal off the potentially toxic material.
Similar articles
-
Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.J Neurochem. 2000 Feb;74(2):721-9. doi: 10.1046/j.1471-4159.2000.740721.x. J Neurochem. 2000. PMID: 10646524
-
Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.J Neurobiol. 2002 Oct;53(1):1-10. doi: 10.1002/neu.10094. J Neurobiol. 2002. PMID: 12360578
-
Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.Neurotoxicology. 2004 Sep;25(5):761-9. doi: 10.1016/j.neuro.2004.05.002. Neurotoxicology. 2004. PMID: 15288507
-
What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?J Neural Transm Suppl. 2003;(65):73-88. doi: 10.1007/978-3-7091-0643-3_5. J Neural Transm Suppl. 2003. PMID: 12946050 Review.
-
Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders.Antioxid Redox Signal. 2005 May-Jun;7(5-6):672-84. doi: 10.1089/ars.2005.7.672. Antioxid Redox Signal. 2005. PMID: 15890012 Review.
Cited by
-
α-synuclein, LRRK2 and their interplay in Parkinson's disease.Future Neurol. 2012 Mar;7(2):145-153. doi: 10.2217/fnl.12.2. Future Neurol. 2012. PMID: 22563296 Free PMC article.
-
A chronic mouse model of Parkinson's disease has a reduced gait pattern certainty.Neurosci Lett. 2007 Dec 11;429(1):39-42. doi: 10.1016/j.neulet.2007.09.060. Epub 2007 Oct 5. Neurosci Lett. 2007. PMID: 17977658 Free PMC article.
-
Impact of exercise on mitochondrial transcription factor expression and damage in the striatum of a chronic mouse model of Parkinson's disease.Neurosci Lett. 2011 Nov 21;505(3):268-72. doi: 10.1016/j.neulet.2011.10.036. Epub 2011 Oct 21. Neurosci Lett. 2011. PMID: 22040668 Free PMC article.
-
G-CSF promotes autophagy and reduces neural tissue damage after spinal cord injury in mice.Lab Invest. 2015 Dec;95(12):1439-49. doi: 10.1038/labinvest.2015.120. Epub 2015 Nov 2. Lab Invest. 2015. PMID: 26524416
-
α-Synuclein oligomers with broken helical conformation form lipoprotein nanoparticles.J Biol Chem. 2013 Jun 14;288(24):17620-30. doi: 10.1074/jbc.M113.476697. Epub 2013 Apr 22. J Biol Chem. 2013. PMID: 23609437 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
